First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
この論文をさがす
収録刊行物
-
- The Lancet
-
The Lancet 389 (10083), 2031-2040, 2017-05
Elsevier BV
